$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Prevention and treatment of cardiovascular pathologies 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/445
  • A61K-031/40
  • A61K-031/38
  • A61K-031/135
출원번호 US-0486334 (1995-06-07)
발명자 / 주소
  • Grainger David J.,GB2
  • Metcalfe James C.,GB2
  • Kunz Lawrence L.
  • Schroff Robert W.
  • Weissberg Peter L.,GB2
출원인 / 주소
  • NeoRx Corporation
대리인 / 주소
    Schwegman, Lundberg, Woessner & Kluth, P.A.
인용정보 피인용 횟수 : 109  인용 특허 : 158

초록

A method for treating or preventing cardiovascular pathologies by administering a compound of the formula (I): [ STR 1 ] wherein Z is C.dbd.O or a covalent bond; Y is H or O(C.sub.1 -C.sub.4)alkyl, R.sup.1 and R.sup.2 are individually (C.sub.1 -C.sub.4)alkyl or together with N are a saturated hetero

대표청구항

[ What is claimed is:] [1.] A therapeutic method comprising inhibiting smooth muscle cell (SMC) proliferation associated with procedural vascular trauma comprising the systemic administration to a mammal subjected to said procedure, an effective cytostatic SMC proliferative inhibitory amount of a co

이 특허에 인용된 특허 (158)

  1. Schickaneder Helmut (Poing DEX) Lser Roland (Feldafing DEX) Grill Helmut (Vaterstetten DEX), 1,1,2-triphenylbut-1-ene derivatives.
  2. Crawley Graham C. (Macclesfield GB2), 1-Hydrocarbyloxyphenyl-1,2-diphenylalkene derivatives.
  3. Jones C. David (Indianapolis IN) Suarez Tulio (Indianapolis IN), 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents.
  4. Godfrey Alexander G. (Greenwood IN), 2-amino-3-aroyl-benzo[b 상세보기
  • Harper, Michael J. K.; Richardson, Dora N.; Walpole, deceased, Arthur L., Alkene derivatives.
  • Sachs Clifford W. (Durham NC) Fine Robert L. (Durham NC) Ballas Lawrence M (Apex NC) Carroll R. Ivy (Durham NC) Bell Robert (Durham NC), Aminoanthraquinone derivatives to combat multidrug resistance.
  • Labrie Fernand (Quebec CAX) Merand Yves (Quebec CAX), Anti-estrogenic compounds and compositions.
  • Harita ; Kozaburo ; Ajisawa ; Yukiyoshi ; Iizuka ; Kinji ; Kinoshita ; Y ukihiko ; Kamijo ; Tetsuhide ; Kobayashi ; Michihiro, Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same.
  • Jones Charles D. (Indianapolis IN), Antiestrogenic and antiandrugenic benzothiophenes.
  • Suarez Tulio (Indianapolis IN) Jones C. David (Indianapolis IN), Antifertility compounds.
  • Suarez Tulio (Indianapolis IN) Jones C. David (Indianapolis IN), Antifertility compounds.
  • Woods W. T. (R.R. 1-Box 13 Chatham IL 62629), Apparatus and method for angioplasty and for preventing re-stenosis.
  • Harita Kozaburo (Hongo JA) Ajisawa Yukiyoshi (Okaya JA) Iizuka Kinji (Matsumoto JA) Kinoshita Yukihiko (Matsumoto JA) Kamijo Tetsuhide (Shiojiri JA) Kobayashi Michihiro (Toyoshina JA), Aromatic carboxylic amide derivatives.
  • Harita Kozaburo (Osaka JPX) Ajisawa Yukiyoshi (Nagano JPX) Iizuka Kinji (Nagano JPX) Kinoshita Yukihiko (Nagano JPX) Kamijo Tetsuhide (Nagano JPX) Kobayashi Michihiro (Nagano JPX), Aromatic carboxylic amide derivatives.
  • Milius Richard A. (Boston MA) Lambrecht Richard M. (Quogue NY) Bloomer William D. (Wilton CT), Astatinated organic compounds.
  • Shaffer Maureen A. (Miami FL) Leone James E. (Miami FL), Balloon catheter for delivering therapeutic agents.
  • Fontana Steven A. (Martinsville IN), Benzofurans used to inhibit bone loss.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN), Benzothiopene compounds, compositions, and method of inhibiting restenosis.
  • Palkowitz Alan D. (Carmel IN), Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN), Benzothiophene compounds, compositions, and methods for inhibiting aortal smooth muscle proliferation.
  • Stack Richard S. (Chapel Hill NC) Clark Howard G. (Durham NC) Walker William F. (Holcomb NY) McElhaney James H. (Durham NC), Bioabsorbable stent and method of making the same.
  • Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  • Slepian Marvin J. (Cleveland Heights OH) Schindler Anton (Durham NC), Biodegradable polymeric endoluminal sealing process.
  • Narciso ; Jr. Hugh L. (Santa Barbara CA), Biogenic implant for drug delivery and method.
  • Barath Peter (West Hollywood CA) Denes Ferenc (Budapest HUX), Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to.
  • Barath Peter (West Hollywood CA) Denes Ferenc (Budapest HUX), Catheter device for intramural delivery of therapeutic agents.
  • Shiozawa Akira (Omiya JPX) Inubushi Atsuro (Tokyo JPX) Narita Kazuhisa (Ageo JPX) Sagawa Yukihiro (Yono JPX) Hosono Makoto (Kitamoto JPX) Iida Masashi (Kitamoto JPX), Certain chroman derivatives useful for treating symptoms caused by contraction of smooth muscles, circulatory diseases o.
  • Flanagan Richard J. (Hudson CAX) Charleson F. Peter (Kirkland CAX), Chelate derivatives of atrial natriuretic factor (ANF).
  • Franckowiak Gerhard (Wuppertal DEX) Stoltefuss Jrgen (Haan DEX) Bechem Martin (Wuppertal DEX) Gross Rainer (Wuppertal DEX) Kayser Michael (Leverkusen DEX) Hebisch Siegbert (Oberhausen DEX) Schramm Ma, Circulation-active fluoromethoxyphenyl dihydropyridine compounds.
  • Purchio Anthony F. (Seattle WA) Madisen Linda (Seattle WA) Webb Nancy (College Station TX), Cloning and expression of transforming growth factor b 상세보기
  • Eppstein Deborah A. (Palo Alto CA) Schryver Brian B. (Redwood City CA), Controlled release of macromolecular polypeptides.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK), Cyclopropyl analogs as anti-estrogenic, anti-tumor and female fertility agents.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK), Cyclopropyl analogs as estrogenic and anti-fertility agents.
  • Fildes Francis J. T. (Macclesfield GB2) Hutchinson Francis G. (Macclesfield GB2), Delivery means for biologically active agents.
  • Laurencin Cato T. (Somerville MA) Lucas Paul A. (Macon GA) Syftestad Glenn T. (Sacramento CA) Domb Abraham (Baltimore MD) Glowacki Julianne (Jamaica Plan MA) Langer Robert S. (Newton MA), Delivery system for controlled release of bioactive factors.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Avor Kwasi S. (Columbia MO), Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Avor Kwasi S. (Columbia MO), Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents.
  • Choi ; Nam Sok ; Heller ; Jorge, Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates).
  • Wallace Sidney (Houston TX) Yang David (Sugarland TX) Wallace Michael (Houston TX), Efficient microcapsule preparation and method of use.
  • Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO), Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use.
  • Thompson David D. (Gales Ferry CT), Estrogen agonists as remedies for prostate and cardiovascular diseases.
  • Sabel Bernhard A. (Kreuzberg 6 8011 Egmating MA DEX) Freese Andrew (115 Whitcomb Ave. Jamaica Plain MA 02130), Extended drug delivery of small, water-soluble molecules.
  • Brandley Brian K. (Alameda CA) Lam Lun H. (Cupertino CA) Laine Roger A. (Alameda CA), Heparin fragments as inhibitors of smooth muscle cell proliferation.
  • Yang David J. (Sugarland TX) Wallace Sidney (Houston TX), High affinity halogenated-tamoxifen derivatives and uses thereof.
  • Yang David J. (Sugarland TX) Wallace Sidney (Houston TX), High affinity tamoxifen derivatives and uses thereof.
  • Sonnenschein Carlos (Boston MA) Soto Ana M. (Boston MA), In-vitro methods for identifying compositions which are agonists and antagonists of estrogens.
  • Kleinschroth Jrgen (Denzlingen DEX) Hartenstein Johannes (Stegen-Wittental DEX) Schchtele Christoph (Freiburg DEX) Rudolph Claus (Vrstetten DEX), Indolocarbazoles and the use thereof.
  • Clarke Richard H. (Scituate MA), Inhibition of restenosis by ultraviolet radiation.
  • Deckelbaum Lawrence I. (Woodbridge CT) Gasparro Francis P. (Hamden CT) Sumpio Bauer K. (New Haven CT), Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light.
  • Kodama Kazuhisa (Takarazuka JPX) Hirayama Atsushi (Osaka JPX) Masayasu Hiroyuki (Tokyo JPX), Inhibitor for restenosis after percutaneous coronary arterioplasty.
  • Clader John W. (Cranford NJ) Davis Harry R. (Berkeley Heights NJ) Mullins Deborra (New York NY) Rosenblum Stuart (West Orange NJ) Weinstein Jay (Upper Montclair NJ), Inhibitors of platelet-derived growth factor.
  • Fischell Robert E. (14600 Viburnum Dr. Dayton MD 21036) Fischell Tim A. (1018 Chancery La. Nashville TN 37215) Fischell David R. (71 Riverlawn Dr. Fair Haven NJ 07704), Integrated catheter system for balloon angioplasty and stent delivery.
  • Fischell Robert E. (Dayton MD) Fischell Tim A. (Los Altos CA), Intra-arterial stent with the capability to inhibit intimal hyperplasia.
  • McCague Raymond (Reigate GB2), Iodotamoxifen derivatives and use for estrogen receptor-positive breast cancer detection and therapy.
  • Miyazono Kohei (Uppsala SEX) Heldin Carl-Henrik (Uppsala SEX) Olofsson Anders (Uppsala SEX), Isolated, large latent complexes of TGF-bb 상세보기
  • Miyazono Kohei (Uppsala SEX) Heldin Carl-Henrik (Uppsala SEX) Olofsson Anders (Uppsala SEX), Isolated, large latent complexes of TGF-bb 상세보기
  • Kauffman Raymond F. (11420 Saint Andrews La. Carmel IN 46032) Singh Jai P. (13774 Hill Crest Ct. Carmel IN 46032), Local delivery of dipyridamole for the treatment of proliferative diseases.
  • Charmot Dominique (Paris FRX) Vidil Christine (Paris FRX), Magnetizable composite microspheres of hydrophobic crosslinked polymer, process for preparing them and their application.
  • Benita Simon (Jerusalem ILX) Levy Menashe (Jerusalem ILX), Medicinal emulsions.
  • Slepian Marvin J. (Cleveland Heights OH), Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens.
  • Spears J. Richard (Winchester MA) Bourgelais Donna (Malden MA), Method for angioplasty.
  • March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN), Method for delivery of smooth muscle cell inhibitors.
  • Crissman Harry A. (Los Alamos NM) Gadbois Donna M. (Los Alamos NM) Tobey Robert A. (Los Alamos NM) Bradbury E. Morton (Santa Fe NM), Method for distinguishing normal and transformed cells using G1 kinase inhibitors.
  • Sales James J. (Indianapolis IN), Method for increasing libido in post-menopausal women.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Method for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B]thien-3-yl-4-[2-(piperidin-1-yl)ethoxyphenyl.
  • Williams Daniel C. (Fishers IN), Method for inhibiting cartilage degradation.
  • Fontana Steven A. (Martinsville IN), Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives.
  • Ondetti Miguel A. (Princeton NJ) Aberg A. K. Gunnar (Lawrenceville NJ) Ferrer Patricia (Pennington NJ), Method for preventing onset of restenosis after angioplasty employing an ace inhibitor.
  • McGovern Mark E. (Philadelphia PA) Ondetti Miguel A. (Princeton NJ) Pan Henry Y. (Princeton Junction NJ), Method for preventing onset of restenosis after angioplasty employing pravastatin.
  • March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN) Patton Brian L. (Thorntown IN), Method for preventing restenosis following reconfiguration of body vessels.
  • Yang Na N. (Indianapolis IN), Method for screening anti-osteoporosis agents.
  • Tamai Hideo (Moriyama JPX) Ueda Kinzo (Kusatsu JPX) Hsu Yung-sheng (Moriyama JPX), Method for the inhibition of restenosis associated with coronary intervention.
  • Wolinsky Harvey (175 Riverside Dr. New York NY 10024), Method for the prevention of restenosis.
  • Hupe Donald (Ann Arbor MI) Keiser Joan A. (Ann Arbor MI), Method for treating vascular proliferative disorders following balloon angioplasty.
  • Greenwald James E. (St. Louis MO), Method for treatment of arterial stenosis.
  • Harker Laurence A. (San Diego CA) Hanson Stephen R. (Encinitas CA), Method of inhibiting platelet dependent arterial thrombosis.
  • Cullinan George J. (Trafalgar IN), Method of inhibiting seborrhea and acne.
  • Gregory Clare R. (Davis CA) Morris Randall E. (Los Altos CA), Method of treating hyperproliferative vascular disease.
  • Mitchell Robert D. (Doylestown PA) Skwish Stephen (Mercer NJ), Method of treating hyperproliferative vascular disease.
  • Morris Randall E. (Stanford CA) Bartlett Robert R. (Darmstadt DEX), Method of treating hyperproliferative vascular disease.
  • Stromberg Brent V. (511 Corley Dr. Chesterfield MO 63017), Method of treating peripheral vasoconstriction with tamoxifen citrate.
  • Spears James R. (Boston MA), Method of treatment of atherosclerosis and a balloon catheter for same.
  • Daddona Peter E. (West Chester PA) Berger Harvey J. (Devon PA) McEver Rodger P. (Oklahoma City OK), Methods for imaging atherosclerotic plaque.
  • Fontana Steven A. (Martinsville IN), Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Methods for inhibiting bone loss.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Methods for inhibiting bone loss using substituted benzothiophene.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Methods for inhibiting uterine fibrosis.
  • Singh Jai P. (Carmel IN) Wiernicki Todd R. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell migration.
  • Cullinan George J. (Trafalgar IN) Singh Jai P. (Carmel IN) Wood Dan L. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell proliferation and restinosis.
  • Cullinan George J. (Trafalgar IN) Singh Jai P. (Carmel IN) Wood Dan L. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell proliferation and restinosis.
  • Cullinan George J. (Trafalgar IN) Singh Jai P. (Carmel IN) Wood Dan L. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell proliferation and restinosis.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Methods for lowering serum cholesterol.
  • Bryant Henry U. (Indianapolis IN) Dodge Jeffrey A. (Indianapolis IN), Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and u.
  • Cullinan George J. (Trafalgar IN) Termine John D. (Indianapolis IN), Methods for the treatment of peri-menopausal syndrome.
  • Dodge Jeffrey A. (Indianapolis IN), Methods of inhibiting Turner\s syndrome.
  • Grinnell Brian W. (Indianapolis IN), Methods of inhibiting cell-cell adhesion.
  • Glasebrook Andrew L. (Zionsville IN), Methods of inhibiting demyelinating and desmyelinating diseases.
  • Keohane Patrick (Indianapolis IN), Methods of inhibiting dysfunctional uterine bleeding.
  • Zuckerman Steven H. (Indianapolis IN), Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes.
  • Fontana Steven A. (Martinsville IN), Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder.
  • Sall Daniel J. (Greenwood IN) Smith Gerald F. (Indianapolis IN), Methods of inhibiting thrombin.
  • Sall Daniel J. (Greenwood IN) Smith Gerald F. (Indianapolis IN), Methods of inhibiting thrombin.
  • Cullinan George J. (Trafalgar IN), Methods of inhibiting ulcerative mucositis.
  • Dodge Jeffrey A. (Indianapolis IN) Sato Masahiko (Carmel IN), Methods of inhibiting vascular restenosis.
  • Schreiber Alan D. (Philadelphia PA), Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc recepto.
  • Purchio Anthony F. (Seattle WA) Madisen Linda (Seattle WA) Merwin June R. (Clinton CT), Methods using novel chimeric transforming growth factor-bb 상세보기
  • Scher Herbert B. (Moraga CA) Rodson Marius (El Cerrito CA), Microcapsules.
  • Wolf Peter A. (100 Stevens Ave. Valhalla NY 10595) Havekotte Margaret J. (74 Byram Terrace Dr. Greenwich CT 06830), Microemulsions of oil in water and alcohol.
  • Lee Haibang (Daejun-si KRX) Yuk Soonhong (Daejun-si KRX), Microencapsulation for controlled oral drug delivery system.
  • Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN) Lugar Charles W. (McCordsvi, Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell prolifera.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN) Lugar Charles W. (McCordsvi, Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis.
  • Conrad H. Edward (Alameda CA) Guo Yuchuan (Alameda CA), Non-anticoagulant heparin derivatives.
  • Gitter Bruce D. (Carmel IN) Lunn William H. W. (Indianapolis IN), Non-peptide tachykinin receptor antagonists to treat allergy.
  • Lioubin Mario N. (Bellevue WA) Brown Thomas J. (Seattle WA) Purchio Anthony F. (Seattle WA), Normal human growth regulatory receptor for TGF-b 상세보기
  • Toivola Reijo J. (Oulu FIX) Karjalainen Arto J. (Oulu FIX) Kurkela Kauko O. A. (Oulu FIX) Soderwall Marja-Liisa (Oulu FIX) Kangas Lauri V. M. (Turki FIX) Blanco Guillermo L. (Oulu FIX) Sunduiqst Hann, Novel tri-phenyl alkane and alkene derivatives and their preparation and use.
  • Derynk Rik M. A. (So. San Francisco CA) Goeddel David V. (Forestview CA), Nucleic acid encoding TGF-b 상세보기
  • Marquardt Hans (Mercer Island WA) Zarling Joyce M. (Seattle WA) Shoyab Mohammed (Seattle WA) Hanson Marcia B. (Seattle WA) Lioubin Mario N. (Bellevue WA) Brown Thomas J. (Seattle WA) Ikeda Tatsuhiko , Oncostatin M and novel compositions having anti-neoplastic activity.
  • Fretto Larry J. (Sausalito CA), PDGF receptor blocking peptides.
  • Hock Janet M. (Indianapolis IN), Parathyroid hormone and raloxifene for increasing bone mass.
  • Shlyankevich Mark (Waterbury CT), Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis.
  • Demopoulos Harry B. (Scarsdale NY), Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis fol.
  • Bisaccia Emil (4 Sunnybrook Rd. Basking Ridge NJ 07920) Klainer Albert S. (315 W. 70th St. New York NY 10023), Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty.
  • Novak Sarah T. A. (Cary NC) Soll Richard M. (Lawrenceville NJ) Ellingboe John W. (Princeton NJ) Nguyen Thomas T. (Philadelphia PA), Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation.
  • Grainger David J. (Cambridge GB2) Metcalfe James C. (Cambridge GB2) Weissberg Peter L. (Cambridge GB2), Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Grainger David J. (Cambridge GBX) Metcalfe James C. (Cambridge GBX) Weissberg Peter L. (Cambridge GBX), Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Bindschaedler Christian (4 route de Malagny CH 1294 Genthold CHX) Gurny Robert (7 rue Calvin CH 1204 Geneva CHX) Doelker Eric (24 avenue Dumas CH 1206 Geneva CHX), Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powd.
  • Platz Robert M. (Half Moon Bay CA) Ip Anna (Moorpark CA) Whitham Clyde L. (Montara CA), Process for preparing micronized polypeptide drugs.
  • O\Toole Michael P. (Norwalk CT), Process for producing small polymer phase droplet microemulsions by multistep aqueous phase addition.
  • Burch Ronald M. (Silver Spring MD) Patch Raymond J. (Baltimore MD) Shearer Barry G. (Baltimore MD) Perumattam John J. (Baltimore MD), Protein kinase C modulators.
  • Dake Michael D. (1915 Mandeville Canyon Rd. Los Angeles CA 90049) Hedger Bruce (16220 Gundry Ave. Paramount CA 90723) Oesterle Stephen (101 Burlingame Ave. Los Angeles CA 90049), Radioactive catheter.
  • Cox Edward T. (Foster City CA) Mather Jennie P. (Millbrae CA) Sliwkowski Mary B. (San Carlos CA) Woodruff Teresa K. (Millbrae CA), Receptor polypeptides and their production and uses.
  • Dror Michael (Edina MN) Trescony Paul (Robbinsdale MN), Releasable coatings on balloon catheters.
  • Niikura Kazuaki (Ibaraki JPX) Nakajima Yoshimitsu (Ibaraki JPX) Notsu Yoshitada (Ibaraki JPX) Ono Ryuji (Ibaraki JPX) Nakayama Osamu (Ibaraki JPX), Remedies for bone diseases.
  • Grafe Ingomar (Nuremberg DEX) Schickaneder Helmut (Eckental DEX) Jungblut Peter W. (Hanover DEX) Ahrens Kurt H. (Nuremberg DEX), Stable solvent adducts of Z-1-(p-b 상세보기
  • Williams Michael S. (Cupertino CA), Stent capable of attachment within a body lumen.
  • Ichijo Hidenori (Upsala SEX) Miyazono Kohei (Upsala SEX) Rnnstrand Lars (Upsala SEX) Hellman Ulf (Upsala SEX) Wernstedt Christer (Upsala SEX) Heldin Carl-Henrik (Upsala SEX), Substantially pure receptor like TGF-b 상세보기
  • Conrad H. Edward (Alameda CA) Fugedi Peter (Alameda CA) Brandley Brian K. (Alameda CA) Lam Lun H. (Cupertino CA) Laine Roger A. (Alameda CA), Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation.
  • Black Larry J. (Indianapolis IN) Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Sulfonate derivatives of 3-aroylbenzo[b]thiophenes.
  • Peters, Mary K., Synthesis of acylated benzothiophenes.
  • Purchio Anthony F. (Seattle WA) Skonier John E. (Seattle WA) Neubauer Michael G. (Seattle WA), TGF-b 상세보기
  • Brown Dennis M. (Menlo Park CA) Luck Edward (Menlo Park CA) Twardzik Daniel R. (Bainbridge Island WA) Purchio Anthony F. (Seattle WA), TGF-b 상세보기
  • Srinivasan Ananthachari (Kirkland WA) Brixner Diana I. (Lynnwood WA) Vrudhula Vivekananda M. (Edmonds WA), Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages.
  • Labrie Fernand (Quebec CAX) Merand Yves (Quebec CAX), Therapeutic antiestrogens.
  • Abiuso Christopher L. (Miami FL) Leone James E. (Miami FL), Therapeutic porous balloon catheter.
  • Baldus Berthold (Berlin DEX) Maass Bernhard (Berlin DEX) Mller Bernd (Berlin DEX) Witt Werner (Berlin DEX), Thrombosis treatment with fibrinolytics and prostacyclins.
  • Casscells Ward M. (La Jolla CA) Lappi Douglas A. (Del Mar CA) Baird J. Andrew (San Diego CA), Treatment of vascular injury.
  • Toivola Reijo J. (Oulu FIX) Karjalainen Arto J. (Oulu FIX) Kurkela Kauko O. A. (Oulu FIX) Soderwall Marja-Liisa (Oulu FIX) Kangas Lauri V. M. (Turku FIX) Blanco Guillermo L. (Oulu FIX) Sundquist Hann, Tri-phenyl alkane derivatives and their oestrogenic, anti-oestrogenic and progestanic uses.
  • Toivola Reijo J. (Oulu FIX) Karjalainen Arto J. (Oulu FIX) Kurkela Kauko O. A. (Oulu FIX) Soderwall Marja-Liisa (Oulu FIX) Kangas Lauri V. M. (Turku FIX) Blanco Guillermo L. (Oulu FIX) Sundquist Hann, Tri-phenyl alkene derivatives and their preparation and use.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Day Billy W. (Newtonville MA), Triarylcyclopropanes as antiestrogens and antitumor agents.
  • Ruenitz Peter C. (Clarke City GA), Triarylethylene carboxylic acids with estrogenic activity.
  • Fischell Robert E. (Dayton MD) Fischell Tim A. (Los Altos CA), Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct.
  • Hansson Gran (Dr Linds gata 6 S-413 25 Gteborg SEX) Holm Jan (nggardsplatsen 8 S-413 19 Gteborg SEX) Jonasson Lena (Grna gatan 8 S0575 33Eksj SEX), Use of gamma-interferon for the treatment of vascular stenosis.
  • Na George C. (Fort Washington PA) Rajagopalan Natarajan (Phoenixville PA), Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization.
  • Harris Adrian L. (83 Kingston Road Oxford OX2 64J GB3) Kangas Lauri V. M. (Pasantie 3 B 21280 Raisio CT FIX) DeGregorio Michael W. (93 Leatherman Trail Hamden CT 06518), Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs.
  • Ohlstein Eliot H. (Glenmoore PA), Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell pr.
  • Yue Tian-Li (Havertown PA) Ohlstein Eliot H. (Glenmoore PA) Feuerstein Giora Z. (Wynnewood PA), Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and prolifer.
  • Lewis Jerome M. (Newton MA) Menz Edward T. (Quincy MA) Kenny Francis E. (Watertown MA) Groman Ernest V. (Brookline MA) Josephson Lee (Arlington MA), Vascular magnetic resonance imaging agent comprising nanoparticles.
  • 이 특허를 인용한 특허 (109)

    1. Pacetti, Stephen Dirk; DesNoyer, Jessica; Chen, Yung Ming; Kleiner, Lothar; Hossainy, Syed F. A., Abluminal, multilayer coating constructs for drug-delivery stents.
    2. Ylikorkala, Olavi; Metsa-Heikkila, Merja; Hietanen, Paivi; Ellmen, Juha, Agent for lowering endothelin levels.
    3. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
    4. Cheng, Jin; Dugan, Stephen; Stewart, Gordon; Zhang, Gina; Kirsten, Nancy; Consigny, Paul; Feezor, Christopher; Park, Gene; Roorda, Wouter; Hossainy, Syed F. A., Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device.
    5. Dugan, Stephen, Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device.
    6. Dugan, Stephen, Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device.
    7. Dugan, Stephen, Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device.
    8. Dugan, Stephen, Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device.
    9. Chen, Yung Ming; Tang, Fuh Wei, Apparatus and method for electrostatic coating of an abluminal stent surface.
    10. Kokish, Lyudmila, Balloon catheter for delivering therapeutic agents.
    11. Kokish, Lyudmila; Pacetti, Stephen D.; Stankus, John, Balloon catheter for delivering therapeutic agents.
    12. Kokish,Lyudmila, Balloon catheter for delivering therapeutic agents.
    13. Fox, William Jason; Harold, Nathan; Garcia, Antonio; Tochterman, Andrew, Bioabsorbable stent with prohealing layer.
    14. Ding, Ni; Michal, Gene; Pacetti, Stephen D., Carbon coating on an implantable device.
    15. Hunter, William L., Composition and methods of paclitaxel for treating psoriasis.
    16. Hunter, William L., Compositions and methods for treating surgical adhesions.
    17. Grainger, David J.; Tatalick, Lauren Marie; Kanaly, Suzanne T., Compounds and methods to inhibit or augment an inflammatory response.
    18. Grainger,David J.; Tatalick,Lauren Marie, Compounds and methods to inhibit or augment an inflammatory response.
    19. Grainger,David J.; Tatalick,Lauren Marie, Compounds and methods to inhibit or augment an inflammatory response.
    20. Grainger,David J.; Tatalick,Lauren Marie; Kanaly,Suzanne T., Compounds and methods to inhibit or augment an inflammatory response.
    21. David J. Grainger GB; James C. Metcalfe GB; Sudhakar Kasina, Compounds and therapies for the prevention of vascular and non-vascular pathologies.
    22. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Kasina Sudhakar, Compounds and therapies for the prevention of vascular and non-vascular pathologies.
    23. Grainger, David J.; Metcalfe, James C.; Kasina, Sudhakar, Compounds and therapies for the prevention of vascular and non-vascular pathologies.
    24. Grainger,David J.; Metcalfe,James C.; Kasina,Sudhakar, Compounds and therapies for the prevention of vascular and non-vascular pathologies.
    25. Grainger,David J.; Metcalfe,James C.; Kasina,Sudhakar, Compounds and therapies for the prevention of vascular and non-vascular pathologies.
    26. Grainger, David J.; Tatalick, Lauren M, Compounds to inhibit or augment an inflammatory response.
    27. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Crush recoverable polymer scaffolds.
    28. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Crush recoverable polymer scaffolds.
    29. Dobson, Andrew Hornby, Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A.
    30. Gale, David C.; Huang, Bin, Drug delivery after biodegradation of the stent scaffolding.
    31. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    32. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    33. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    34. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
    35. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
    36. Shanley,John F.; Eigler,Neal L.; Park,Kinam; Edelman,Elazer R., Expandable medical device for delivery of beneficial agent.
    37. Shanley, John F., Expandable medical device with S-shaped bridging elements.
    38. Shanley, John F., Expandable medical device with beneficial agent concentration gradient.
    39. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
    40. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
    41. Shanley, John F., Expandable medical device with ductile hinges.
    42. Shanley, John F., Expandable medical device with ductile hinges.
    43. Demopoulos, Harry B.; Davis, Kevin, Glutathione formulation and method of use.
    44. Shanley, John F.; Parker, Theodore L.; Park, Kinam, Implantable medical device with beneficial agent concentration gradient.
    45. Shanley,John F.; Parker,Theodore L., Implantable medical device with drug filled holes.
    46. Hunter William L.,CAX ; March Keith L., Intrapericardial delivery of anti-microtubule agents.
    47. Kutryk, Michael J. B.; Cottone, Jr., Robert J.; Rowland, Stephen M., Medical device with coating for capturing genetically-altered cells and methods for using same.
    48. Fox, Jason; Harold, Nathan; Templin, Barry; Tochterman, Andrew, Method for selectively coating surfaces of a stent.
    49. James L. Kinsella ; Steven J. Sollott, Method for treating atherosclerosis or restenosis using microtubule stabilizing agent.
    50. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Method of crimping stent on catheter delivery assembly.
    51. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Method of crimping stent on catheter delivery assembly.
    52. Weisman,Kenneth M.; Goldberg,Michael, Method of decreasing atherosclerosis and its complications.
    53. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Method of making a stent.
    54. Wu, Patrick P., Method of making stents with radiopaque markers.
    55. Wu, Patrick P., Method of making stents with radiopaque markers.
    56. Yan,John Y.; Chan,Randy, Method of reducing or eliminating thrombus formation.
    57. Wu, Patrick P., Method of removing stent islands from a stent.
    58. James L. Kinsella ; Steven J. Sollot, Method of treating atherosclerosis or restenosis using microtubule stabilizing agent.
    59. James L. Kinsella ; Steven J. Sollot, Method of treating atherosclerosis or restenosis using microtubule stabilizing agent.
    60. Day, Wesley W.; Lee, Andrew G.; Thompson, David D., Methods and kits for improving vascular health.
    61. Hossainy, Syed F. A.; Sridharan, Srinivasan; Jacobs, James, Methods for manufacturing a coated stent-balloon assembly.
    62. Crutcher Keith A. ; Harmony Judith A. K., Methods for the treatment of apolipoprotein E related diseases.
    63. Grainger, David J.; Tatalick, Lauren Marie, Methods to inhibit or augment an inflammatory response.
    64. Lamb,Fred S., Methods to reduce the sensitivity of endothelially-compromised vascular smooth muscle.
    65. Craig, Charles H.; Papp, John E.; Jayasinghe, Dudley; Hines, Lionel G.; Orosa, Dennis, Nanobead releasing medical devices.
    66. Ludwig, Florian N., Nanoshell therapy.
    67. Ludwig, Florian Niklas, Nanoshell therapy.
    68. Ludwig, Florian N.; Pacetti, Stephen D.; Hossainy, Syed F. A.; Davalian, Dariush, Nanoshells for drug delivery.
    69. Ludwig, Florian Niklas; Pacetti, Stephen D.; Hossainy, Syed F. A.; Davalian, Dariush, Nanoshells on polymers.
    70. Ludwig, Florian Niklas; Pacetti, Stephen D.; Hossainy, Syed F. A.; Davalian, Dariush, Nanoshells on polymers.
    71. Ludwig, Florian Niklas; Pacetti, Stephen D.; Hossainy, Syed F. A.; Davalian, Dariush, Nanoshells on polymers.
    72. Levy, Robert J.; Alferiev, Ivan; Stachelek, Stanley; Connolly, Jeanne M.; Christian, Abigail, Oxidation resistant bioprosthetic tissues and preparation thereof.
    73. Anukhin, Boris; Ngo, Michael H.; Trollsas, Mikael; Hossainy, Syed; Papp, John, Polymer scaffolds having a low crossing profile.
    74. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Kunz Lawrence L. ; Schroff Robert W. ; Weissberg Peter L.,GBX, Prevention and treatment of cardiovascular pathologies.
    75. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of cardiovascular pathologies.
    76. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Kunz Lawrence L. ; Schroff Robert W., Prevention and treatment of cardiovascular pathologies with tamoxifen analogues.
    77. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
    78. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
    79. Cottone, Jr., Robert John; Yoklavich, Margaret; Parker, Sherry, Progenitor endothelial cell capturing with a drug eluting implantable medical device.
    80. Van Sciver, Jason, Rotatable support elements for stents.
    81. Van Sciver, Jason, Rotatable support elements for stents.
    82. Van Sciver, Jason, Rotatable support elements for stents.
    83. Van Sciver, Jason, Rotatable support elements for stents.
    84. Van Sciver, Jason, Rotatable support elements for stents.
    85. Pacetti, Stephen; Bei, Joan; Wang, Karen; Liu, Annie, Scaffolds having radiopaque markers.
    86. Hossainy,Syed F. A.; Mirzaee,Daryush, Selective coating of medical devices.
    87. Tochterman, Andrew J.; Fox, William J.; Harold, Nathan, Selectively coating luminal surfaces of stents.
    88. Alt, Eckhard, Stent device and method.
    89. Fox, Jason; Harold, Nathan; Templin, Barry; Tochterman, Andrew, Stent mandrel fixture and method for selectively coating surfaces of a stent.
    90. Fox,Jason; Harold,Nathan; Templin,Barry; Tochterman,Andrew, Stent mandrel fixture and method for selectively coating surfaces of a stent.
    91. Pacetti,Stephen D.; Villareal,Plaridel K., Stent mounting assembly and a method of using the same to coat a stent.
    92. Shanley,John F., Stent wall structure.
    93. Shanley,John F., Stent wall structure.
    94. Wu, Patrick P., Stent with radiopaque markers.
    95. Dugan, Stephen R.; Abbate, Anthony J., Stents with radiopaque markers.
    96. Dugan, Stephen R.; Abbate, Anthony J., Stents with radiopaque markers.
    97. Wu, Patrick P., Stents with radiopaque markers.
    98. Wu, Patrick P., Stents with radiopaque markers.
    99. Chen, Yung Ming; Ho, Henjen, System and method for coating an implantable medical device.
    100. Shanley, John F.; Parker, Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
    101. Shanley,John F.; Parker,Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
    102. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    103. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    104. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    105. Kunz, Lawrence L.; Reno, John M., Therapeutic inhibitor of vascular smooth muscle cells.
    106. Lawrence L. Kunz ; John M. Reno, Therapeutic inhibitor of vascular smooth muscle cells.
    107. Weisman Kenneth M. ; Goldberg Michael, Therapeutic uses of goserelin acetate.
    108. Wieland, Heinrich; Schmidt, Alfred, Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof.
    109. Lamb,Fred S.; Schutte,Brian C.; Yang,Baoli, Use of ClC3 chloride channel blockers to modulate vascular tone.

    문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로